Sotradecol (Page 2 of 2)
DOSAGE AND ADMINISTRATION
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Do not use if precipitated or discolored.
Sotradecol (sodium tetradecyl sulfate injection) is for intravenous use only. The strength of solution required depends on the size and degree of varicosity. In general, the 1% solution will be found most useful with the 3% solution preferred for larger varicosities. The dosage should be kept small, using 0.5 mL to 2 mL (preferably 1 mL maximum) for each injection, and the maximum single treatment should not exceed 10 mL.
HOW SUPPLIED
Sotradecol® (sodium tetradecyl sulfate injection)
NDC 67457-162-02
carton containing 5 x 2 mL multiple-dose vials with 1% 20 mg/2 mL (10 mg/mL)
NDC 67457-163-02
carton containing 5 x 2 mL multiple-dose vials with 3% 60 mg/2 mL (30 mg/mL)
STORAGE
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
ANIMAL TOXICOLOGY
The intravenous LD50 of sodium tetradecyl sulfate in mice was reported to be 90 ± 5 mg/kg.
In the rat, the acute intravenous LD50 of sodium tetradecyl sulfate was estimated to be between 72 mg/kg and 108 mg/kg.
Purified sodium tetradecyl sulfate was found to have an LD50 of 2 g/kg when administered orally by stomach tube as a 25% aqueous solution to rats. In rats given 0.15 g/kg in drinking water for 30 days, no appreciable toxicity was seen, although some growth inhibition was discernible.
Manufactured for:
Mylan Institutional LLC
Morgantown, WV 26505 U.S.A.
Manufactured by:
Mylan Institutional
Galway, Ireland
Revised: 8/2021
MI:SOTRIJ:R7
0521L112
® Sotradecol is a registered trademark of Mylan Pharma Group Limited
PRINCIPAL DISPLAY PANEL — 10 mg/mL Carton Label
NDC 67457-162-02
Sotradecol® 1%
(sodium tetradecyl sulfate injection)
20 mg/2 mL (10 mg/mL)
For Intravenous Use Only
Rx only 5 x 2 mL Multiple-Dose Vials
Each mL contains: Sodium tetradecyl sulfate 10 mg, benzyl alcohol 0.02 mL
and dibasic sodium phosphate, anhydrous 4.0 mg in Water for Injection. pH 7.9; monobasic
sodium phosphate and/or sodium hydroxide added, if needed, for pH adjustment.
WARNING: Do not use if precipitated.
Usual Dosage: See accompanying
prescribing information.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room Temperature.]
Manufactured for:
Mylan Institutional LLC
Morgantown, WV 26505 U.S.A.
Manufactured by:
Mylan Institutional Galway, Ireland
MI:162:5C:R7
Mylan.com
PRINCIPAL DISPLAY PANEL — 30 mg/mL Carton Label
NDC 67457-163-02
Sotradecol® 3%
(sodium tetradecyl sulfate injection)
60 mg/2 mL (30 mg/mL)
For Intravenous Use Only
Rx only 5 x 2 mL Multiple-Dose Vials
Each mL contains: Sodium tetradecyl sulfate 30 mg, benzyl alcohol 0.02 mL and
dibasic sodium phosphate, anhydrous 9.0 mg in Water for Injection. pH 7.9; monobasic
sodium phosphate and/or sodium hydroxide added, if needed, for pH adjustment.
WARNING: Do not use if precipitated.
Usual Dosage: See accompanying
prescribing information.
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled RoomTemperature.]
Manufactured for:
Mylan Institutional LLC
Morgantown, WV 26505 U.S.A.
Manufactured by:
Mylan Institutional Galway, Ireland
MI:163:5C:R7
Mylan.com
SOTRADECOL tetradecyl hydrogen sulfate (ester) injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
SOTRADECOL tetradecyl hydrogen sulfate (ester) injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Mylan Institutional LLC (790384502) |
Revised: 08/2021 Mylan Institutional LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.